Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

S&P 500 Inches Higher Following Hottest Inflation Report in Decades

Published 01/13/2022, 04:28 AM
© Reuters.

By Yasin Ebrahim – The S&P 500 was marginally higher Wednesday, as data showing inflation hitting the fastest pace in decades, which was largely expected, failed to spook investors.

The S&P 500 rose 0.2%, the Dow Jones Industrial Average slipped 0.1%, or 44 points, the Nasdaq added 0.2%.

The consumer price index rose 0.6% in December, just above expectations for a 0.5% increase, taking the year-on-year consumer prices through December to 7%, in-line with expectations and the fastest rate since 1982.

A deeper look into the report, however, showed sticker areas of price pressures, particularly from the services sector, rose by less than expected, stoking early hopes that inflation may cool in the months ahead.

“[C]ore services rose by just 0.3%, the slowest since September. Housing inflation did not accelerate as we expected, and price increases slowed in travel categories,” {{Jefferies said in a note}}.  

But even if price pressure ease in “three months, or six months from now that’s not going to move the dial in time for the Fed to start making changes to how they're thinking about tapering or rate hikes,” Johan Grahn, head of ETF Strategy at Allianz (DE:ALVG) told in an interview on Wednesday.

Following the inflation report, Treasury yields continued to slip, with the 10-year backing further away from 1.8%, paving the way for an ongoing recovery in tech.

Big tech was mostly higher, led by Alphabet (NASDAQ:GOOGL), though Meta Platforms (NASDAQ:FB) was the exception, down more than 1%.              

Tesla (NASDAQ:TSLA), meanwhile, jumped 4% a day after receiving a price upgrade from Morgan Stanley to $1,300 per share from $1,200.

A fall in health care kept a lid on gains in the broader market following a more than 7% slump in Biogen (NASDAQ:BIIB) after Medicare said it planned to only cover the company’s Alzheimer's drug, Aduhelm, for patients enrolled in approved clinical trials.

PayPal (NASDAQ:PYPL), meanwhile, slipped 2% after {{0|Jefferies downgraded the company to a hold from buy and cut its price target on the stock  to $200 From $255, citing a cautious fundamental backdrop in 2022.

Energy was flat even as oil prices neared two-month highs following a larger-than-expected draw in weekly crude inventories. Energy prices will likely "continue to surge- as demand from economic reopening and reflation collides with a cold snap and tight supply in the Northeast region," Janney Montgomery Scott said in a note. "We remain bullish on crude oil prices- and expect targets toward the $85-90 range in 2022."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.